About this journal

  Pharmacogenomics is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this rapdly developing field. Pharmacogenomics focuses on those aspects that have the most direct relevance to the pharmaceutical industry and wider clinical community including: the emegence of new pharmacogenomics initiatives and their impact on R&D and regulatory strategies; emerging technologies for accessing and exploiting genomic information; reviews of genotyping and clinical data in particular therapeutic areas; development of novel diagnostic products and strategies. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.

Associate Editors

Gurwitz D, Tel-Aviv University, IL
Innocenti F, University of Chicago, USA
Karas Kuželički K, University of Ljubljana, Slovenia

Editorial Advisory Board

Altman RB, Stanford University, USA
Aquilante C, University of Colorado, USA
Brockmöller J, Georg August University Göttingen, Germany
Burckart G, CDER-FDA, USA
Burczynski M, F. Hoffmann-La Roche Ltd, USA
Cascorbi I, University Hospital Schleswig-Holstein, Germany
Cohen N, Johnson and Johnson Pharmaceutical R&D, USA
Daly A, University of Newcastle, UK
Dolzan V, University of Ljubljana
Duconge J, University of Puerto Rico, Puerto Rico
Gaedigk A, Children's Mercy Hospital, USA
Guchelaar H-J, Leiden University Medical Center, Netherlands
Hakonarson H, deCODE Genetics, Iceland
Hardiman G, University of California, USA
Hein D, University of Louisville, USA
Hertz D, University of Michigan, USA
Ingelman-Sundberg M, Karolinska Institute, Sweden
Ishikawa T, RIKEN Omics Science Center, Japan
Johnson J, University of Florida, USA 
Kamali F, University of Newcastle, UK
Klein R, University of South Florida College of Medicine, USA
Krajinovic M, Professor, University of Montreal
Krauss R, Children's Hospital Oakland Research Institute, USA
Kudzi W, University of Ghana Medical School, Ghana
Lamba J, University of Minnesota, USA
Lee S-Y, Sungkyunkwan University School of Medicine, Republic of Korea
Leeder S, Children's Mercy Hospital and Clinics, USA
Llerena A, Hospital Universitario Infanta Cristina, Spain
Lötsch J, Johann Wolfgang Goethe-University, Germany
Maitland-van der zee A, Utrecht University, Netherlands
Manolopoulos V, Democritus University of Thrace, Greece
Marsh S, University of Alberta, Canada
McCarthy A, PGxis, UK
Motsinger-Reif A, North Carolina State University, USA
Müller D, University of Toronto, Canada
Newman W, University of Manchester, UK
Niemi M, Helsinki University Central Hospital, Finland
Patrinos G, University of Patras, Greece
Pirmohamed M, University of Liverpool, UK
Ramesar R, MRC Human Genetics, South Africa
Ritchie M, University of Pennsylvania, USA
Roukos D, Ioannina University, Greece
Ruaño G, Genomas, USA
Sadhasivam S, Indiana University School of Medicine
Santini D, University Campus Bio-Medico University, Italy
Shah RR, Pharmaceutical Consultant, UK
Shin J-G, Inje University College of Medicine, Republic of Korea
Spraggs C, GlaxoSmithKline Research & Development, UK
Squassina A, University of Cagliari, Italy
Stebbing J, Imperial College of Medicine, UK
Stingl J, Federal Institute for Drugs and Medical Devices, Germany
Suarez-Kurtz G, Instituto Nacional de Cancer, Brazil
Telenti A, Scripps Research Institute, USA
van Schaik R, Erasmus University Medical Center, Netherlands
Wadelius M, Uppsala University, Sweden
Wolf CR, University of Dundee, UK
Wong S, Medical College of Wisconsin
Yoshikawa, RIKEN Brain Science Institute, Japan
Zanger U, Margarete Fischer-Bosch Institute, Germany
Zembutsu H, National Cancer Center, Japan
Zhang W, Central South University, China